BRPI9600729B8 - vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada - Google Patents

vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada

Info

Publication number
BRPI9600729B8
BRPI9600729B8 BRPI9600729A BRPI9600729B8 BR PI9600729 B8 BRPI9600729 B8 BR PI9600729B8 BR PI9600729 A BRPI9600729 A BR PI9600729A BR PI9600729 B8 BRPI9600729 B8 BR PI9600729B8
Authority
BR
Brazil
Prior art keywords
cloning
protein
preparing
nucleic acid
expression vector
Prior art date
Application number
Other languages
English (en)
Inventor
Xavier Chenivesse
Catherine Duport
Eric Lecain
Denis Pompon
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9501723A external-priority patent/FR2730494B1/fr
Priority claimed from FR9506517A external-priority patent/FR2734839B1/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BRPI9600729A publication Critical patent/BRPI9600729A/pt
Publication of BRPI9600729B1 publication Critical patent/BRPI9600729B1/pt
Publication of BRPI9600729B8 publication Critical patent/BRPI9600729B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/02—Dehydrogenating; Dehydroxylating

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI9600729 1995-02-15 1996-02-14 vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada BRPI9600729B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9501723 1995-02-15
FR9501723A FR2730494B1 (fr) 1995-02-15 1995-02-15 Sequence d'adn codant pour une proteine d'a. thaliana ayant une activite delta-5,7 sterol, delta-7 reductase, proteine delta7-red, procede de production, souches de levures transformees, applications
FR9506517A FR2734839B1 (fr) 1995-06-01 1995-06-01 Sequence d'adn codant pour une proteine d'a. thaliana ayant une activite delta-5,7 sterol, delta-7 reductase, proteine delta-7red, procede de production, souches de levures transformees, applications.
FR9506517 1995-06-01

Publications (3)

Publication Number Publication Date
BRPI9600729A BRPI9600729A (pt) 1997-12-23
BRPI9600729B1 BRPI9600729B1 (pt) 2017-06-20
BRPI9600729B8 true BRPI9600729B8 (pt) 2021-07-06

Family

ID=26231759

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9600729 BRPI9600729B8 (pt) 1995-02-15 1996-02-14 vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada

Country Status (24)

Country Link
US (3) US5759801A (pt)
EP (1) EP0727489B1 (pt)
JP (1) JP4082469B2 (pt)
KR (1) KR100422293B1 (pt)
CN (2) CN1664107A (pt)
AR (2) AR003407A1 (pt)
AT (1) ATE457354T1 (pt)
BR (1) BRPI9600729B8 (pt)
CA (1) CA2169524C (pt)
CZ (1) CZ294860B6 (pt)
DE (1) DE69638123D1 (pt)
DK (1) DK0727489T3 (pt)
ES (1) ES2339833T3 (pt)
FI (1) FI120877B (pt)
HR (1) HRP960078B1 (pt)
HU (1) HU220587B1 (pt)
IL (4) IL162476A (pt)
PL (1) PL185569B1 (pt)
PT (1) PT727489E (pt)
RU (1) RU2242517C2 (pt)
SI (1) SI0727489T1 (pt)
SK (1) SK283656B6 (pt)
TR (1) TR199600116A2 (pt)
UA (1) UA72172C2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997048793A1 (en) * 1996-06-21 1997-12-24 The General Hospital Corporation Plant sterol reductases and uses thereof
DE19739940A1 (de) * 1997-09-11 1999-03-18 Hartmut Prof Dr Med Glossmann Protein mit Aminosäuresequenz der DELTA7-Sterolreduktase, isoliertes cDNA-Molekül, das für das Protein kodiert, rekombinanter DNA-Vektor und biologisch aktive Zusammensetzungen, die das Protein oder das cDNA-Molekül enthalten
FR2774393B1 (fr) * 1998-02-05 2000-03-24 Hoechst Marion Roussel Inc Souches de levure ayant le gene atf2 interrompu et leurs applications
US6465717B1 (en) * 1998-11-20 2002-10-15 E. I. Du Pont De Nemours And Company Sterol metabolism enzymes
FR2812884B1 (fr) * 2000-08-08 2002-11-08 Aventis Pharma Sa Levures modifiees et utilisations, notamment pour la production de derives steroidiens
FR2820145B1 (fr) * 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome
US7193169B2 (en) * 2003-10-29 2007-03-20 Alcon, Inc. Ergonomic footswitch
FR2869914B1 (fr) * 2004-05-06 2012-11-09 Aventis Pharma Sa Souches de levure produisant du cholesterol et leurs applications
CA2600882C (en) * 2005-03-16 2013-02-26 Metabolix, Inc. Chemically inducible expression of biosynthetic pathways
KR100672006B1 (ko) * 2005-08-03 2007-01-19 길병옥 폐자재를 이용한 형강의 제조방법 및 그 제조방법에 의해생산된 형강
PT2227549E (pt) * 2007-12-21 2015-10-08 Novartis Ag Sistema de seleção para cultura de células eucarióticas com base num gene de recetor de folato ligado à membrana
DE102009022772A1 (de) 2009-05-21 2010-11-25 Organobalance Gmbh Mikroorganismus zur Expression eines humanen Membranproteins
FR2961218A1 (fr) 2010-06-10 2011-12-16 Sanofi Aventis Methode de detection de composes modulateurs du metabolisme du cholesterol
CN102286053B (zh) * 2011-06-20 2012-09-05 河北联合大学 孕甾烯醇酮吡咯化合物及其制备方法
KR20160019451A (ko) * 2013-06-17 2016-02-19 사노피 시토크롬 p450 모노옥시게나제 생체촉매작용을 위한 전세포 시스템
CN110903993A (zh) * 2019-12-20 2020-03-24 河北兰升生物科技有限公司 一种产生菜籽甾醇的酿酒酵母工程菌及其构建方法和应用
CN112813129B (zh) * 2021-02-05 2023-09-08 江南大学 利用区室化提高酵母菌中7-脱氢胆固醇产量的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1042567A (zh) * 1988-09-23 1990-05-30 吉斯特-布罗卡迪斯公司 类固醇多步氧化方法和所用的遗传工程细胞
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
US5547868A (en) * 1993-06-09 1996-08-20 Regents Of The University Of California Cholesterol disposal fusion enzymes

Also Published As

Publication number Publication date
HUP9600325A3 (en) 1999-07-28
PT727489E (pt) 2010-04-27
CN1145953A (zh) 1997-03-26
ATE457354T1 (de) 2010-02-15
JPH08289793A (ja) 1996-11-05
DK0727489T3 (da) 2010-05-31
AR003407A1 (es) 1998-08-05
JP4082469B2 (ja) 2008-04-30
IL162476A (en) 2005-12-18
TR199600116A2 (tr) 1996-08-21
EP0727489A1 (fr) 1996-08-21
KR960031607A (ko) 1996-09-17
IL116872A (en) 2004-12-15
CN1664107A (zh) 2005-09-07
US5989881A (en) 1999-11-23
FI960663A (fi) 1996-08-16
EP0727489B1 (fr) 2010-02-10
HRP960078B1 (en) 2011-11-30
ES2339833T3 (es) 2010-05-25
IL162476A0 (en) 2005-11-20
HRP960078A2 (pt) 1998-02-28
UA72172C2 (uk) 2005-02-15
PL185569B1 (pl) 2003-06-30
HUP9600325A1 (en) 1996-11-28
US5965417A (en) 1999-10-12
CA2169524C (fr) 2012-05-01
CZ294860B6 (cs) 2005-04-13
SI0727489T1 (sl) 2010-05-31
AR053931A2 (es) 2007-05-23
KR100422293B1 (ko) 2004-06-14
PL312828A1 (en) 1996-08-19
IL162477A0 (en) 2005-11-20
FI960663A0 (fi) 1996-02-14
HU220587B1 (hu) 2002-03-28
CN1216995C (zh) 2005-08-31
DE69638123D1 (de) 2010-03-25
US5759801A (en) 1998-06-02
SK18896A3 (en) 1996-10-02
IL116872A0 (en) 1996-07-23
CZ43296A3 (en) 1996-12-11
BRPI9600729B1 (pt) 2017-06-20
FI120877B (fi) 2010-04-15
BRPI9600729A (pt) 1997-12-23
SK283656B6 (sk) 2003-11-04
RU2242517C2 (ru) 2004-12-20
CA2169524A1 (fr) 1996-08-16

Similar Documents

Publication Publication Date Title
BRPI9600729B8 (pt) vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada
BR9508053A (pt) Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga
BR9509890A (pt) Polipeptídeo sequencia de dna ou rna vetor célula hospedeira e processo para produzir um polipeptídeo
BR1100704KB1 (pt) vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli.
BR9401842A (pt) Sequência isolada de DNA, gene quimérico, vetor para a transformação de plantas, cepa de agrobacterium SP, céllula vegetal transformada, planta transformada e processo de construção de um gene quimérico
BR9710871B1 (pt) Construção do DNA; vetor; e método para modificar geneticamente uma planta.
BR9509715B1 (pt) vetor, processo para produção de planta transgênica e processo para introdução de pelo menos dois genes em uma planta.
AU2086199A (en) Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof
AU4802896A (en) Phosphonomonoester nucleic acids, process for their preparation, and their use
AU6096896A (en) Modified nucleotides for nucleic acid labeling
DE69636866D1 (en) Reverse "two-hybrid"-systeme
FI960331A (fi) Gandida utilis -hiivan transformointisysteemit ja vieraiden geenien ilmentäminen niiden avulla
BR9608375B1 (pt) gene quimérico, vetor, processo de transformação de plantas e processo de tratamento herbicida seletivo de plantas.
BR9401321A (pt) Muteína, sequência de DNA, vetor, célula, sequência de RNA composto, processo para sua preparação, composição farmacêutica e uso.
EP0590747A3 (en) Beta-6-N-acetylglucosaminyltransferase, the leukosialin acceptor and method for cloning proteins with enzymatic activity.
BR9101137A (pt) Metodo para a preparacao de um vetor hibrido,processo para a preparacao de uma molecula de dna,metodo para a preparacao de um hospedeiro e para a preparacao de um polipeptidio e metodo para a preparacao de psm puro
BR9500271A (pt) Sequência de DNA vetor,plasmídeo,célula,proteína,mutante processo para o isolamento de ácidos nucléicos processo para a preparação de açúcares e empr egno
BR9508714A (pt) Composto processo de preparação de estreptogramas por muta-síntese sequencia nucleotídica dna recombinante vetor utilização de uma sequencia e/ou de um vetor polipetídeo cepa mutante e composição farmacèutica
BR8507148A (pt) Vetor de transferencia de dna recombinante cepa de bacterias,sequencia dna;metodo para diagnosticar uma mutacao no gene receptor de ldl de um individuo
WO1998044104A3 (de) Flip-gen und flip-protein
BR9506862A (pt) Sequência de nucleotídeos polipeptídeo vetor célula hospedeira planta hospedeira ou parte da mesma planta ou parte da mesma e processo para alterar as caracteristica fisicas da uma planta ou parte da mesma
FI896261A0 (fi) Foerfarande foer framstaellning av ett protein eller en polypeptid, dna-sekvens som kodar foer polypeptiden, mikroorganism innehaollande dna-sekvensen samt polypeptiden och dess anvaendning som ett farmaceutiskt preparat.
NO981322L (no) Farmas÷ytiske preparater for bruk ved nukleinsyretransfeksjon, og deres anvendelse
BR9306150A (pt) Endo--1,4-glucanase sequéncia de dna recombinante vetor hospedeiro transformado contendo o vetor processo para a produç o de endo- -1,4-glucanase preparaç o de enzima e uso de endo- -1,4-glucanase
DK0840802T3 (da) Fremgangsmåde til sekvensering gennem oligomerhybridisering

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: HOECHST MARION ROUSSEL (FR)

Free format text: TRANSFERIDO POR FUSAO DE: ROUSSEL-UCLAF

B25A Requested transfer of rights approved

Owner name: AVENTIS PHARMA S.A. (FR)

Free format text: TRANSFERIDO DE: HOECHST MARION ROUSSEL

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE A MATERIA PLEITEADA NAS REIVINDICACOES 1 A 3 NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA (ART. 8O COMBINADO COM ART. 13 DA LPI).

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24D Patent annual fee: restoration after fee payment
B15K Others concerning applications: alteration of classification

Ipc: C12N 15/81 (2006.01), C12N 15/74 (2006.0

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/02/96, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO